Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02669966 · ClinicalTrials.gov registry record · NA
Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR
A NA study of Hepatitis C and ESRD, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
- 1
- Study location
NCT02669966: Completed NA study of Hepatitis C and ESRD, sponsored by University of Florida.
NCT02669966 is a NA study of Hepatitis C and ESRD that has completed, run by University of Florida. The registered enrollment target is 2 participants, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02669966, a NA study of Hepatitis C and ESRD, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
- 1
- Study location
Study Summary
It is well recognized that a subset of patients who contracts Hepatitis C virus (HCV) spontaneously clears the virus. Such individuals are anti-HCV antibody positive, yet HCV RNA PCR negative in the blood. While they have not been considered candidates for live kidney donation in the past, with the recent availability of novel anti-HCV drugs with \>95% cure rates, they now represent a potential pool of donor candidates, especially since the risk for transmission of HCV to the recipient is extremely low. The investigators goal is to demonstrate that live kidney donation from anti-HCV positive, HCV RNA PCR negative individuals is safe and carries a negligible risk of viral transmission to the recipient.
Primary Outcome
At 3 months post-transplant, recipients will be screened for HCV seropositivity. A negative seropositive result will conclude the recipient's participation in the study
Conditions Studied
Interventions
- PROCEDURE Kidney transplantation
Study Locations (1)
Florida
- Shands at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-02 |
| Phase | NA |
What the finished NCT02669966 record still lists
NCT02669966 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,890-participant average among 106 other Hepatitis C trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Hepatitis C appearing as the primary indexed condition, and to 1 intervention - of which Kidney transplantation is the first listed.
NCT02669966 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02669966 about?
NCT02669966 is a clinical study titled "Live Kidney Donors With Positive Anti-HCV Antibody, But Negative HCV PCR". It is well recognized that a subset of patients who contracts Hepatitis C virus (HCV) spontaneously clears the virus. Such individuals are anti-HCV antibody positive, yet HCV RNA PCR negative in the blood. While they have not been considered candidates for live kidney donation in the past, with the ...
What is the current status of trial NCT02669966?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2016-03. Estimated completion is 2020-02.
What conditions does trial NCT02669966 study?
This clinical trial studies the following conditions: Hepatitis C, ESRD.
What interventions are being tested in trial NCT02669966?
The interventions under investigation include: Kidney transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT02669966?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02669966 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02669966's enrollment target sits among peer trials
2 106th of 106 the lowest of 106 other Hepatitis C trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
RECRUITING · NA
-
HCV Tappt Adherence Study
RECRUITING · NA
-
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
RECRUITING · NA
-
Buprenorphine Integration Research and Community Health
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia